• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    55 Biggest Movers From Friday

    4/4/22 4:59:19 AM ET
    $AERC
    $ALLG
    $AUID
    $AVTE
    Environmental Services
    Utilities
    Automotive Aftermarket
    Consumer Discretionary
    Get the next $AERC alert in real time by email

    Gainers

    • Takung Art Co., Ltd. (NASDAQ:TKAT) surged 61.8% to close at $3.64 on Friday.
    • Chicken Soup for the Soul Entertainment, Inc. (NASDAQ:CSSE) rose 43.8% to settle at $11.49 on Friday after the company reported Q4 earnings results.
    • Manning & Napier, Inc. (NYSE:MN) shares surged 40.4% to close at $12.79 on Friday after the company reported it will be acquired by Callodine Group and will go private at $12.85 per share.
    • Hudson Capital Inc. (NASDAQ:HUSN) gained 36.3% to settle at $2.63 after the company announced it sold its wholly-owned subsidiary, Hong Kong Internet Financial Services, to private investors.
    • Greenidge Generation Holdings Inc. (NASDAQ:GREE) jumped 34% to close at $11.52 after the company reported Q4 financials results.
    • Weidai Ltd. (NYSE:WEI) jumped 28.8% to close at $1.43 on above-average volume.
    • AeroClean Technologies, Inc. (NASDAQ:AERC) gained 27.2% to close at $4.58. AeroClean Technologies recently posted a Q4 loss of $0.13 per share.
    • Clovis Oncology, Inc. (NASDAQ:CLVS) jumped 23.8% to close at $2.50. Clovis Oncology recently announced positive topline data from the monotherapy arm of Phase 3 ATHENA-MONO trial of Rubraca (Rucaparib) as first-line maintenance treatment in ovarian cancer.
    • ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) rose 23.6% to close at $6.60.
    • Evolve Transition Infrastructure LP (NASDAQ:SNMP) gained 22.6% to close at $0.6389.
    • Leju Holdings Limited (NYSE:LEJU) jumped 21.4% to close at $0.8218. The company, last week, reported FY21 results.
    • HeartCore Enterprises, Inc. (NASDAQ:HTCR) rose 21.2% to close at $3.49.
    • Borr Drilling Limited (NYSE:BORR) jumped 20.9% to close at $4.05.
    • Avalo Therapeutics, Inc. (NASDAQ:AVTX) gained 20.2% to settle at $0.8712.
    • Tellurian Inc. (NYSE:TELL) rose 19.6% to close at $6.34. Credit Suisse upgraded Tellurian from Neutral to Outperform and raised the price target from $5.5 to $8.
    • Blackboxstocks Inc. (NASDAQ:BLBX) shares gained 19.4% to close at $3.20 after the company reported better-than-expected Q4 sales results.
    • Dolphin Entertainment, Inc. (NASDAQ:DLPN) jumped 17.5% to close at $6.12.
    • GreenPower Motor Company Inc. (NASDAQ:GP) surged 16.8% to settle at $8.00. GreenPower Motor, last month, said its purpose-built buses and trucks are eligible for vouchers through the California Air Resources Board (CARB) Hybrid and Zero-Emission Truck and Bus Voucher Incentive Project (HVIP).
    • Fresh Vine Wine, Inc. (NYSE:VINE) surged 16.4% to close at $3.90.
    • Ipsidy Inc. (NASDAQ:AUID) gained 16.1% to close at $4.55.
    • Immuneering Corporation (NASDAQ:IMRX) jumped 15% to close at $7.44. Oppenheimer initiated coverage on Immuneering with an Outperform rating and announced a price target of $25.
    • NGM Biopharmaceuticals, Inc. (NASDAQ:NGM) surged 14.7% to close at $17.50. NGM Bio announced initiation of Phase 1/1b clinical trial of NGM831 for the treatment of patients with advanced solid tumors.
    • Haynes International, Inc. (NASDAQ:HAYN) gained 14.5% to close at $48.80 after KeyBanc maintained an Overweight rating on the stock and raised its price target from $41 to $55.
    • Lulu's Fashion Lounge Holdings, Inc. (NASDAQ:LVLU) gained 14.3% to close at $7.75 following Q4 results.
    • Sigma Lithium Corporation (NASDAQ:SGML) gained 14.3% to close at $15.53.
    • nCino, Inc. (NASDAQ:NCNO) rose 13.7% to close at $46.58 following strong quarterly sales.
    • DiDi Global Inc. (NYSE:DIDI) shares gained 12.8% to close at $2.82. Shares of several Chinese stocks traded higher following reports indicating Chinese authorities are preparing to give U.S. regulators full access to auditing reports of most of the companies listed on American exchanges.
    • Society Pass Incorporated (NASDAQ:SOPA) rose 10.1% to close at $3.27.
    • Dada Nexus Limited (NASDAQ:DADA) gained 9.3% to close at $9.98. Shares of several Chinese stocks traded higher following reports indicating Chinese authorities are preparing to give U.S. regulators full access to auditing reports of most of the companies listed on American exchanges.
    • U.S. Xpress Enterprises, Inc. (NYSE:USX) gained 7.7% to close at $4.18.
    • LSB Industries, Inc. (NYSE:LXU) gained 6.1% to close at $23.17.

     


    Losers

    • SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) shares tumbled 37.9% to close at $4.15 on Friday after the company announced an exclusive license agreement with GenFleet in which the company will pay GenFleet a total of up to $150 million. The company also announced a $25 million common stock offering.
    • Cyren Ltd. (NASDAQ:CYRN) dropped 36% to close at $3.23 on above-average volume.
    • Redwire Corporation (NYSE:RDW) fell 28.7% to settle at $6.05 after the company reported FY21 earnings results and issued FY22 sales guidance.
    • Pulse Biosciences, Inc. (NASDAQ:PLSE) fell 27% to close at $3.55 after the company reported worse-than-expected Q4 EPS and sales results.
    • Digital Brands Group, Inc. (NASDAQ:DBGI) shares fell 24.7% to close at $1.43 as the company posted a wider quarterly loss.
    • Shapeways Holdings, Inc. (NASDAQ:SHPW) dipped 21% to close at $2.26. Shapeways Holdings posted a Q4 net loss of $2.4 million.
    • Pineapple Holdings, Inc. (NASDAQ:PEGY) dropped 18.9% to settle at $5.07.
    • Vivos Therapeutics, Inc. (NASDAQ:VVOS) fell 18.7% to settle at $2.18. Vivos Therapeutics posted Q4 sales of $4.40 million.
    • Allego N.V. (NYSE:ALLG) dipped 18.5% to close at $12.32 on below-average volume.
    • Spero Therapeutics, Inc. (NASDAQ:SPRO) fell 18.3% to close at $7.11 after the company reported worse-than-expected Q4 EPS and sales results.
    • Greenbrook TMS Inc. (NASDAQ:GBNH) dipped 17.5% to close at $3.10. Greenbrook TMS posted Q4 loss of $0.34 per share.
    • Reed's, Inc. (NYSE:REED) fell 16.3% to settle at $0.2515 as the company reported fourth-quarter revenue growth of 20% year-over-year to $12.8 million, missing the consensus of $13.02 million.
    • Biophytis SA (NASDAQ:BPTS) dropped 16.2% to close at $2.18.
    • Inspirato Incorporated (NASDAQ:ISPO) dropped 16.1% to close at $8.34 on above-average volume.
    • Blend Labs, Inc. (NYSE:BLND) shares fell 15.8% to close at $4.80 after the company reported worse-than-expected Q4 sales results and issued both Q1 and FY22 sales guidance below analyst estimates.
    • Kidpik Corp. (NASDAQ:PIK) fell 15.6% to close at $4.07 following a wider-than-expected quarterly loss.
    • P.A.M. Transportation Services, Inc. (NASDAQ:PTSI) dipped 14.5% to close at $29.70.
    • Duck Creek Technologies, Inc. (NASDAQ:DCT) dropped 13.9% to close at $19.04 after the company issued Q3 sales guidance below analyst estimates.
    • Aerovate Therapeutics, Inc. (NASDAQ:AVTE) dipped 13.3% to close at $15.90.
    • USA Truck, Inc. (NASDAQ:USAK) fell 13% to close at $17.93.
    • 4D pharma plc (NASDAQ:LBPS) fell 12.8% to close at $4.21 as the company posted a FY21 net loss of $32.1 million.
    • GlucoTrack, Inc. (NASDAQ:GCTK) dipped 12.1% to settle at $3.20.
    • Rail Vision Ltd. (NASDAQ:RVSN) fell 12% to close at $2.72.
    • BlackBerry Limited (NYSE:BB) declined 9.5% to close at $6.75 after the company reportedly announced it expects FY23 cyber security to be flat and expects licensing revenue to be minimal.
    Get the next $AERC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AERC
    $ALLG
    $AUID
    $AVTE

    CompanyDatePrice TargetRatingAnalyst
    Avalo Therapeutics Inc.
    $AVTX
    4/9/2026$48.00Outperform
    Wolfe Research
    LSB Industries Inc.
    $LXU
    4/7/2026$14.00Outperform → Sector Perform
    RBC Capital Mkts
    Avalo Therapeutics Inc.
    $AVTX
    4/6/2026$52.00Mkt Outperform
    Citizens
    Sigma Lithium Corporation
    $SGML
    4/3/2026$17.00Neutral → Buy
    BofA Securities
    Sigma Lithium Corporation
    $SGML
    4/2/2026$17.00Neutral → Buy
    BofA Securities
    nCino Inc.
    $NCNO
    4/1/2026$22.00Neutral → Overweight
    Piper Sandler
    Redwire Corporation
    $RDW
    3/9/2026$15.00Hold → Buy
    Truist
    Sigma Lithium Corporation
    $SGML
    2/3/2026$14.00Underperform → Neutral
    BofA Securities
    More analyst ratings

    $AERC
    $ALLG
    $AUID
    $AVTE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Reed's Announces Appointment of Damian Warshall as Chief Operating Officer

    NORWALK, Conn., April 24, 2026 (GLOBE NEWSWIRE) -- Reed's, Inc. (NYSE:REED) ("Reed's" or the "Company"), owner of the nation's leading portfolio of handcrafted, natural ginger beverages, today announced the appointment of Damian Warshall as Chief Operating Officer, effective April 27, 2026. Mr. Warshall is a seasoned consumer packaged goods (CPG) operations executive with deep expertise in scaling beverage manufacturing operations, enhancing supply chain efficiency and driving profitable growth across complex organizations. Most recently, he served as Chief Operating Officer at Pittston Co-Packers, where he led the revitalization of a large-scale beverage manufacturing facility and secure

    4/24/26 4:05:00 PM ET
    $REED

    authID Launches Industry-First Quantum-Resistant Biometric Authentication Platform

    PrivacyKey Platform Integrates NIST Post-Quantum Standards and MPC Cryptographic Key Protection to Eliminate Quantum Threats and Future-Proof Identity Security Denver, April 24, 2026 (GLOBE NEWSWIRE) -- authID, a leader in biometric identity verification, today announced a landmark advancement in identity security: the quantum-hardening of its PrivacyKey™ biometric digital signature platform. This achievement represents the industry's first biometric authentication solution purpose-built to withstand the cryptographic threats posed by quantum computing. Unlike conventional biometric systems that store facial templates on servers, leaving them vulnerable to future quantum-powered decrypt

    4/24/26 8:00:00 AM ET
    $AUID
    Computer Software: Prepackaged Software
    Technology

    Blend to Announce First Quarter 2026 Financial Results on May 7, 2026

    Blend Labs, Inc. (NYSE:BLND), a leading digital origination platform, today announced that the Company's first quarter 2026 financial results will be released after market close on Thursday, May 7, 2026. The Company will host a conference call to discuss its results at 1:30 p.m. PT / 4:30 p.m. ET the same day. A link to the live call can be accessed at the Company's Investor Relations website at investor.blend.com, along with the Company's earnings press release, financial information, and slide presentation. Following the call, a replay will be available at the same website. About Blend Blend Labs, Inc. (NYSE:BLND) is a leading origination platform for digital banking solutions. Fina

    4/23/26 4:00:00 PM ET
    $BLND
    Computer Software: Programming Data Processing
    Technology

    $AERC
    $ALLG
    $AUID
    $AVTE
    SEC Filings

    View All

    Reed's Inc. filed SEC Form 8-K: Regulation FD Disclosure

    8-K - REED'S, INC. (0001140215) (Filer)

    4/24/26 4:30:25 PM ET
    $REED

    Amendment: SEC Form SCHEDULE 13G/A filed by SELLAS Life Sciences Group Inc.

    SCHEDULE 13G/A - SELLAS Life Sciences Group, Inc. (0001390478) (Subject)

    4/24/26 4:11:56 PM ET
    $SLS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form DEFA14A filed by SELLAS Life Sciences Group Inc.

    DEFA14A - SELLAS Life Sciences Group, Inc. (0001390478) (Filer)

    4/23/26 4:10:13 PM ET
    $SLS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AERC
    $ALLG
    $AUID
    $AVTE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer O'Dowd William Iv bought $4,929 worth of shares (3,100 units at $1.59), increasing direct ownership by 0.69% to 450,090 units (SEC Form 4)

    4 - Dolphin Entertainment, Inc. (0001282224) (Issuer)

    3/16/26 7:33:14 PM ET
    $DLPN
    Other Consumer Services
    Consumer Discretionary

    Chief Executive Officer O'Dowd William Iv bought $4,843 worth of shares (2,900 units at $1.67), increasing direct ownership by 0.65% to 446,990 units (SEC Form 4)

    4 - Dolphin Entertainment, Inc. (0001282224) (Issuer)

    3/9/26 4:53:29 PM ET
    $DLPN
    Other Consumer Services
    Consumer Discretionary

    Chief Executive Officer O'Dowd William Iv bought $4,991 worth of shares (3,100 units at $1.61), increasing direct ownership by 0.70% to 444,090 units (SEC Form 4)

    4 - Dolphin Entertainment, Inc. (0001282224) (Issuer)

    3/2/26 8:15:33 PM ET
    $DLPN
    Other Consumer Services
    Consumer Discretionary

    $AERC
    $ALLG
    $AUID
    $AVTE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Ae Red Holdings, Llc sold $231,820,113 worth of shares (21,365,909 units at $10.85) (SEC Form 4)

    4 - Redwire Corp (0001819810) (Issuer)

    4/24/26 4:05:59 PM ET
    $RDW
    Military/Government/Technical
    Industrials

    SEC Form 4 filed by Ae Red Holdings, Llc

    4 - Redwire Corp (0001819810) (Issuer)

    4/22/26 4:05:27 PM ET
    $RDW
    Military/Government/Technical
    Industrials

    SEC Form 4 filed by Espensen Michael

    4 - Dolphin Entertainment, Inc. (0001282224) (Issuer)

    4/21/26 4:54:12 PM ET
    $DLPN
    Other Consumer Services
    Consumer Discretionary

    $AERC
    $ALLG
    $AUID
    $AVTE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Wolfe Research initiated coverage on Avalo Therapeutics with a new price target

    Wolfe Research initiated coverage of Avalo Therapeutics with a rating of Outperform and set a new price target of $48.00

    4/9/26 8:40:45 AM ET
    $AVTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    LSB Industries downgraded by RBC Capital Mkts with a new price target

    RBC Capital Mkts downgraded LSB Industries from Outperform to Sector Perform and set a new price target of $14.00

    4/7/26 8:40:27 AM ET
    $LXU
    Major Chemicals
    Basic Materials

    Citizens initiated coverage on Avalo Therapeutics with a new price target

    Citizens initiated coverage of Avalo Therapeutics with a rating of Mkt Outperform and set a new price target of $52.00

    4/6/26 8:44:25 AM ET
    $AVTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AERC
    $ALLG
    $AUID
    $AVTE
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for RUBRACA issued to CLOVIS ONCOLOGY INC

    Submission status for CLOVIS ONCOLOGY INC's drug RUBRACA (SUPPL-13) with active ingredient RUCAPARIB CAMSYLATE has changed to 'Approval' on 12/21/2022. Application Category: NDA, Application Number: 209115, Application Classification: Efficacy

    12/22/22 4:37:40 AM ET
    $CLVS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for RUBRACA issued to CLOVIS ONCOLOGY INC

    Submission status for CLOVIS ONCOLOGY INC's drug RUBRACA (SUPPL-11) with active ingredient RUCAPARIB CAMSYLATE has changed to 'Approval' on 06/10/2022. Application Category: NDA, Application Number: 209115, Application Classification: Efficacy

    6/13/22 2:20:18 PM ET
    $CLVS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AERC
    $ALLG
    $AUID
    $AVTE
    Leadership Updates

    Live Leadership Updates

    View All

    Reed's Announces Appointment of Damian Warshall as Chief Operating Officer

    NORWALK, Conn., April 24, 2026 (GLOBE NEWSWIRE) -- Reed's, Inc. (NYSE:REED) ("Reed's" or the "Company"), owner of the nation's leading portfolio of handcrafted, natural ginger beverages, today announced the appointment of Damian Warshall as Chief Operating Officer, effective April 27, 2026. Mr. Warshall is a seasoned consumer packaged goods (CPG) operations executive with deep expertise in scaling beverage manufacturing operations, enhancing supply chain efficiency and driving profitable growth across complex organizations. Most recently, he served as Chief Operating Officer at Pittston Co-Packers, where he led the revitalization of a large-scale beverage manufacturing facility and secure

    4/24/26 4:05:00 PM ET
    $REED

    Pulse Biosciences Strengthens Executive Leadership Team

    Appoints Liane Teplitsky as Chief Operating Officer Expands Dr. David Kenigsberg's Chief Medical Officer Role Pulse Biosciences, Inc. (NASDAQ:PLSE), developer of nPulse™ technology using proprietary nanosecond pulsed field ablation (nsPFA™) energy, today announced the strengthening of its executive leadership team with the appointment of Liane Teplitsky as Chief Operating Officer and expanded role of Dr. David Kenigsberg as full-time Chief Medical Officer. Both the appointment of Liane Teplitsky as Chief Operating Officer and Dr. David Kenigsberg's agreement to serve as the Company's Chief Medical Officer on a full-time basis further enhance the Company's strategic alignment to priori

    4/9/26 7:00:00 AM ET
    $PLSE
    Medical/Dental Instruments
    Health Care

    LSB Industries, Inc. Appoints Jonathan Ackerman as an Independent Member of the Board of Directors; Announces Retirement of Steve Packebush

    LSB Industries, Inc. ("LSB" or "the Company"), (NYSE:LXU) today announced that it has appointed Jonathan Z. Ackerman as an independent member of the Board of Directors (the "Board") effective April 2, 2026. Mr. Ackerman will stand for direct election by shareholders for the first time at the annual meeting of stockholders on May 21, 2026 (the "2026 Annual Meeting"). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260402484774/en/Jonathan Ackerman Mr. Ackerman has a lengthy track record as a successful leader in infrastructure development and finance. He has successfully delivered approximately $10 billion of value for investors b

    4/2/26 5:38:00 PM ET
    $LXU
    Major Chemicals
    Basic Materials

    $AERC
    $ALLG
    $AUID
    $AVTE
    Financials

    Live finance-specific insights

    View All

    Blend to Announce First Quarter 2026 Financial Results on May 7, 2026

    Blend Labs, Inc. (NYSE:BLND), a leading digital origination platform, today announced that the Company's first quarter 2026 financial results will be released after market close on Thursday, May 7, 2026. The Company will host a conference call to discuss its results at 1:30 p.m. PT / 4:30 p.m. ET the same day. A link to the live call can be accessed at the Company's Investor Relations website at investor.blend.com, along with the Company's earnings press release, financial information, and slide presentation. Following the call, a replay will be available at the same website. About Blend Blend Labs, Inc. (NYSE:BLND) is a leading origination platform for digital banking solutions. Fina

    4/23/26 4:00:00 PM ET
    $BLND
    Computer Software: Programming Data Processing
    Technology

    Lulus to Report First Quarter 2026 Results on May 13, 2026

    CHICO, Calif., April 22, 2026 (GLOBE NEWSWIRE) -- Lulu's Fashion Lounge Holdings, Inc. ("Lulus" or the "Company") (NASDAQ:LVLU), the women's clothing brand offering modern, feminine styles at accessible prices for every occasion, announced today that the Company will release its first quarter 2026 financial results on Wednesday, May 13, 2026, after market close. The Company will host a conference call and live webcast with the investment community at 5:00 p.m. Eastern Time that same day. The financial results and live webcast will be accessible through the Investor Relations section of the Company's website at https://investors.lulus.com/. To access the call through a conference line, dia

    4/22/26 6:00:00 AM ET
    $LVLU
    Catalog/Specialty Distribution
    Consumer Discretionary

    Borr Drilling Limited - Invitation to Webcast and Conference Call for Q1 2026 Results

    HAMILTON, Bermuda, April 20, 2026 /PRNewswire/ -- Borr Drilling Limited (NYSE:BORR) and (Euronext Growth Oslo: BORR) (the "Company") plans to release its financial results for the first quarter of 2026 after the close of trading on NYSE on Wednesday, May 20, 2026. A conference call and webcast are scheduled for 09:00 New York time (15:00 CEST) on Thursday, May 21, 2026.The earnings report, webcast and accompanying presentation will be available on the Investor Relations section of the Company's website, www.borrdrilling.com.In order to listen to the live presentation, participants may do one of the following:a)    WebcastTo access the webcast, please go to the following link:https://edge.med

    4/20/26 3:29:00 AM ET
    $BORR
    Oil & Gas Production
    Energy

    $AERC
    $ALLG
    $AUID
    $AVTE
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    What Led to the Purchase at Aerovate Therapeutics Inc. on Jun 20?

    Recently, on June 20, 2024, a notable insider purchase was made at Aerovate Therapeutics Inc. Director Ra Capital Management, L.P. bought $1,549,944 worth of shares, acquiring 928,110 units at $1.67 per share as reported in the SEC Form 4. Insider transactions like these are closely watched by investors as they can provide valuable insights into the company's prospects. When analyzing insider transactions, it is essential to look for patterns and trends among multiple transactions to gauge the overall sentiment within the company. Several other SEC Form 4 filings were made around the same time, on June 7, 2024, by various insiders at Aerovate Therapeutics Inc. These included transactions by

    6/21/24 3:23:59 PM ET
    $AVTE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AERC
    $ALLG
    $AUID
    $AVTE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by nCino Inc.

    SC 13D/A - nCino, Inc. (0001902733) (Subject)

    12/12/24 6:29:06 PM ET
    $NCNO
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13D/A filed by Reeds Inc.

    SC 13D/A - REED'S, INC. (0001140215) (Subject)

    12/6/24 4:30:32 PM ET
    $REED

    Amendment: SEC Form SC 13D/A filed by Reeds Inc.

    SC 13D/A - REED'S, INC. (0001140215) (Subject)

    12/4/24 6:11:30 AM ET
    $REED